多原子ALS特征突出显示子集群和性别差异,表明MAPK途径作为治疗点
Lucas Caldi Gomes1, Sonja Hänzelmann2,3,4, Fabian Hausmann3,4
1Technical University of Munich, School of Medicine, rechts der Isar Hospital, Clinical Department of Neurology, Munich, Germany.
Nature communications
|June 7, 2024
概括
这项研究揭示了肌缩性侧面硬化症 (ALS) 中的性别特异性分子变化. 一种MAPK路径抑制剂,特拉美丁尼,显示出治疗潜力,特别是在女性中,为ALS治疗提供了一个新的方向.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 蛋白质组学是指蛋白质组学.
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,有效治疗方法有限.
- 了解早期的分子机制和性别差异对于开发向疗法至关重要.
研究的目的:
- 通过使用多原子方法,研究肌缩性侧面硬化症 (ALS) 的早期和性别特异性的分子机制.
- 识别不同的人类ALS子集群及其相应的分子特征.
- 为了评估向米托基激活蛋白激酶 (MAPK) 途径的治疗潜力.
主要方法:
- 对来自ALS患者和对照组的人类前额叶皮层样本的综合多原子分析 (转录组学, () 蛋白组学,miRNAomics).
- 对四种转基因ALS小鼠模型 (C9orf72-, SOD1-, TDP-43-, FUS-ALS) 的分析.
- 在体外和体内对MAPK抑制剂特拉美丁尼的测试.
主要成果:
- 在ALS中发现了显著的分子变化,男性显示的变化比女性更明显.
- 独特的人类ALS子集群的特点是免疫反应,细胞外基质,线粒体功能和RNA处理的变化.
- 线素激活蛋白激酶 (MAPK) 途径被确定为早期疾病机制.
- 特拉美替尼布在体外和体内均表现出治疗效益,特别是在女性模型中.
结论:
- 多分子分析揭示了ALS中性别特异的分子通路.
- 截然不同的ALS亚群表明异质的疾病进展.
- 用特拉美丁尼布准MAPK通路为ALS提供了潜在的治疗策略,在女性中观察到有效性.
相关概念视频
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


